Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) studyEGA dataset EGAD00001003675
Impact of HR status of first primary LCIS, and other demographic, clinicopathologic or treatment characteristics on risks of second ipsilateral breast cancers by multivariable-adjusted analyses# (n =
cDNA aCGH study of pure DCIS (breast duct carcinoma in situ) without invasive tumor, DCIS associated with IDC (breast invasive duct carcinoma) and its IDC component 23 patients: 6 pure DCIS without in
